Related Experiment Video
Updated: Aug 15, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Cardiovascular disease in children with chronic kidney disease
1Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229-3039, USA. mark.mitsnefes@cchmc.org
Insights
Cardiovascular disease remains a leading cause of death in children with end-stage renal disease (ESRD). Early detection of cardiac issues and risk factors is crucial for improving outcomes in these young patients.
Area of Science:
- Pediatric Nephrology
- Cardiovascular Research
- Public Health
Background:
- Cardiovascular disease (CVD) mortality in children with end-stage renal disease (ESRD) has remained stagnant for 30 years.
- Cardiac disease is the second leading cause of death in pediatric ESRD patients.
- Children with chronic kidney disease (CKD) exhibit a high prevalence of CVD risk factors.
Purpose of the Study:
- To highlight the persistent challenge of cardiovascular disease (CVD) mortality in pediatric end-stage renal disease (ESRD).
- To emphasize the early detection of cardiovascular abnormalities in children with CKD.
- To advocate for early intervention strategies to reduce cardiovascular morbidity and mortality.
Main Methods:
- Review of recent data on CVD risk factors in pediatric CKD patients.
- Identification of early markers for cardiomyopathy (e.g., left ventricular hypertrophy, left ventricular dysfunction).
- Assessment of early atherosclerosis indicators (e.g., carotid artery intima-media thickness, arterial wall stiffness).
Main Results:
- High incidence and prevalence of traditional and CKD-related CVD risk factors in children.
- Frequent detection of early cardiomyopathy markers like left ventricular hypertrophy and dysfunction.
- Common presence of early atherosclerosis markers, including increased carotid artery intima-media thickness and arterial stiffness.
Conclusions:
- Early identification of modifiable CVD risk factors in children with CKD is essential.
- Treatment of asymptomatic CVD in this population may decrease long-term cardiovascular morbidity and mortality.
- Proactive management can improve the cardiovascular health of young adults with a history of childhood CKD.
Abstract:
In children with end-stage renal disease (ESRD), cardiovascular disease (CVD) mortality has not changed for the past 3 decades. Cardiac disease remains the second most common cause of death. Recent data demonstrate a high incidence and prevalence of traditional and chronic kidney disease (CKD)-related CVD risk factors in children. Early markers of cardiomyopathy, such as left ventricular hypertrophy (LVH) and left ventricular dysfunction (LV dysfunction), and early markers of atherosclerosis, such as increased carotid artery intima-media thickness (IMT) and carotid arterial wall stiffness, are frequently found in this patient population. Early identification of modifiable risk factors and treatment of asymptomatic CVD might lead to decrease of cardiovascular morbidity and mortality in young adults who developed CKD during childhood.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
